1MUECK A O,SEEGER H,WALLWIENER D.Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules[].Experimental and Clinical Endocrinology.2001
2DOBRUCKI L W,KALINOWSKI L,DOBRUCKI I T,et al.Statin-stimulated nitric oxide release from endothelium[].Medical Science Monitor.2001
3RIDKER P M,RIFAI N,PFEFFER M A,et al.For the chelesterol and recurrent events (CEAR) investigation, inflammation,pravastain and the risk of coronary events after myocardio infarction in patients with average cholesterol reduction[].Circulation.1988
4ORTEGO M,BUSTOS C,HERNANDEZ-PRESA M A,et al.Atorvastatin reduces NFB activitation and chemokine expression in vascular smooth muscle cells and mononuclear cells[].Atherosclerosis.1999
5SHEPHERD J,COBBE S M,FORDI,et al.Prevention of coronary heart disease with pravaststin in men with hypercholesterol[].The New England Journal of Medicine.1995
6CORSINI A.Fluvastatin: effects beyond cholesterol lowering[].Journal of Cardiovascular Pharmacology.2000
7LAUFS U,GERTZ K,HUANG P,et al.Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice[].Stroke.2000
8WATERS D D,AZAR R R.Should intensive cholesterol lowering play a role in the management of acute coronary syndromes[].The American Journal of Cardiology.2000
4Laufs U,Gertz K,Huang P,et al.Atorvastatin upregulates type Ⅲ nitric oxide synthase in thrombocytes,decreases platelet activation,and protects from cerebral ischemia in normocholesterolemic mice[J].Stroke,2000,31:2437.
5Rosenson RS,Tangney CC.Antiatherothrombotic properties of statins-implications for cardiovascular event reduction[J].JA MA,1998,279:1643.
6Simoons ML,GUSTO IV-ACS Investigators.Effect of glycoprotein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial[J].Lancet,2001,357:1915.
7Cohen M,Antman EM,Murphy SA,et al.Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes[J].Am Heart J,2002,143:63.
9Sawada T,Shite J,Shinke T,et al.Relationship between high sensitive C-reactive protein and coronary plaque component in patients with acute coronary syndrome:virtual histology study[J].J Cardiol,2006,48(3):141.
10Kwang KK.Effects of statins on vascular wall:vasomotor function,inflammation,and plaque stability[J].Cardiovasc Res,2000,47:648.
